The association of S267F variant on NTCP (SLC10A1), a hepatitis B viral surface receptor, and treatment response with pegylated interferon in chronic hepatitis B patients: a multicenter study

被引：0

作者：

Thanapirom, Kessarin ^{[1
,2
]}

Suksawatamnuay, Sirinporn ^{[1
,2
]}

Sukeepaisarnjaroen, Wattana ^{[3
]}

Tanwandee, Tawesak ^{[4
]}

Charatcharoenwitthaya, Phunchai ^{[4
]}

Thongsawat, Satawat ^{[5
]}

Leerapun, Apinya ^{[5
]}

Piratvisuth, Teerha ^{[6
]}

Boonsirichan, Rattana ^{[7
]}

Bunchorntavakul, Chalermrat ^{[8
]}

Pattanasirigool, Chaowalit ^{[9
]}

Pornthisarn, Bubpha ^{[10
]}

Tantipanichtheerakul, Supot ^{[11
]}

Sripariwuth, Ekawee ^{[12
]}

Jeamsripong, Woramon ^{[13
]}

Sanpajit, Theeranun ^{[14
]}

Poovorawan, Yong ^{[15
]}

Komolmit, Piyawat ^{[1
,2
]}

机构：

[1] Div Gastroenterol, Med, Bangkok, Thailand

[2] Ctr Excellence Liver Dis, Med, Bangkok, Thailand

[3] Khon Kaen Univ, Med, Khon Kaen, Thailand

[4] Mahidol Univ, Med, Bangkok, Thailand

[5] Chiang Mai Univ, Med, Bangkok, Thailand

[6] Prince Songkla Univ, Med, Hat Yai, Thailand

[7] Vajira Hosp, Med, Bangkok, Thailand

[8] Rajavithi Hosp, Med, Bangkok, Thailand

[9] Police Gen Hosp, Med, Bangkok, Thailand

[10] Thammasat Univ Hosp, Med, Bangkok, Thailand

[11] Bhumibol Adulyadej Hosp, Med, Bangkok, Thailand

[12] Naresuan Univ, Med, Phitsanulok, Thailand

[13] Buddhachinaraj Hosp, Med, Phitsanulok, Thailand

[14] Phramongkutklao Hosp, Med, Bangkok, Thailand

[15] Chulalongkorn Univ, Pediat, Bangkok, Thailand

来源：

HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

584

引用

页码：291A / 291A

页数：1

共 50 条

[41] A pharmacogenetic study of polymorphisms in interferon pathway genes and response to interferon-α treatment in chronic hepatitis B patients
Wu, Xiaopan
Zhu, Xilin
Zhu, Shuying
Li, Jingyun
Ma, Juan
Li, Zhuo
Li, Hui
Liu, Ying
ANTIVIRAL RESEARCH, 2009, 83 (03) : 252 - 256
[42] Muscle adiposity influences viral response to pegylated interferon plus ribavirin treatment in patients with genotype 1 chronic hepatitis C
Okada, Michiaki
Mizuta, Toshihiko
Kitajima, Yoichiro
Kawaguchi, Yasunori
Iwane, Shinji
Ide, Yasushi
Eguchi, Yuichiro
Anzai, Keizo
Ozaki, Iwata
HEPATOLOGY, 2013, 58 : 1152A - 1152A
[43] CD55 Variant Associated with Pegylated-interferon α Therapy Response in HBeAg-positive Chronic Hepatitis B Patients
Chen, Jiaxuan
Lou, Shuang
Chen, Haitao
Zhou, Bin
Sun, Jian
Hou, Jinlin
Jiang, De-Ke
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (02) : 295 - 303
[44] Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response
Ikeda, Hiroki
Suzuki, Michihiro
Okuse, Chiaki
Yamada, Norie
Okamoto, Masaru
Kobayashi, Minoru
Nagase, Yoshihiko
Takahashi, Hideaki
Matsunaga, Koutarou
Matsumoto, Nobuyuki
Itoh, Fumio
Yotsuyanagi, Hiroshi
Koitabashi, Yu
Yasuda, Kiyomi
Iino, Shiro
HEPATOLOGY RESEARCH, 2009, 39 (08) : 753 - 759
[45] Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study
Brouwer, Willem P.
Chan, Henry L. Y.
Lampertico, Pietro
Hou, Jinlin
Tangkijvanich, Pisit
Reesink, Hendrik W.
Zhang, Wenhong
Mangia, Alessandra
Tanwandee, Tawesak
Montalto, Giuseppe
Simon, Kris
Ormeci, Necati
Chen, Liang
Tabak, Fehmi
Gunsar, Fulya
Flisiak, Robert
Ferenci, Peter
Akdogan, Meral
Akyuz, Filiz
Hirankarn, Nattiya
Jansen, Louis
Wong, Vincent Wai-Sun
Soffredini, Roberta
Liang, Xieer
Chen, Shalom
Groothuismink, Zwier M. A.
Santoro, Rosanna
Jaroszewicz, Jerzy
Ozaras, Resat
Kozbial, Karin
Brahmania, Mayur
Xie, Qing
Chotiyaputta, Watcharasak
Xun, Qi
Pazgan-Simon, Monika
Oztas, Erkin
Verhey, Elke
Montanari, Noe R.
Sun, Jian
Hansen, Bettina E.
Boonstra, Andre
Janssen, Harry L. A.
Brouwer, Willem Pieter
Hansen, Bettina
Verhey, Elke
Boonstra, Andre
Janssen, Harry
Chi, Heng
Sonneveld, Milan
Montanari, Noe Rico
CLINICAL INFECTIOUS DISEASES, 2019, 69 (11) : 1969 - 1979
[46] The S267F variant of sodium taurocholate co-transporting polypeptide is strongly associated with resistance to chronic hepatitis B and high level of serum total bile acids
Huang, Jiancheng
Su, Mingkuan
Chen, Hongbin
Wu, Shuiqing
Chen, Zongyun
LIVER RESEARCH, 2022, 6 (03) : 186 - 190
[47] Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load
Soo Ryang Kim
Ahmed El-Shamy
Susumu Imoto
Ke Ih Kim
Yoshi-hiro Ide
Lin Deng
Ikuo Shoji
Yasuhito Tanaka
Yutaka Hasegawa
Mitsuhiro Ota
Hak Hotta
Journal of Gastroenterology, 2012, 47 : 1143 - 1151
[48] Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load
Kim, Soo Ryang
El-Shamy, Ahmed
Imoto, Susumu
Kim, Ke Ih
Ide, Yoshi-hiro
Deng, Lin
Shoji, Ikuo
Tanaka, Yasuhito
Hasegawa, Yutaka
Ota, Mitsuhiro
Hotta, Hak
JOURNAL OF GASTROENTEROLOGY, 2012, 47 (10) : 1143 - 1151
[49] Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study
Ogawa, Eiichi
Furusyo, Norihiro
Kajiwara, Eiji
Takahashi, Kazuhiro
Nomura, Hideyuki
Maruyama, Toshihiro
Tanabe, Yuichi
Satoh, Takeaki
Nakamuta, Makoto
Kotoh, Kazuhiro
Azuma, Koichi
Dohmen, Kazufumi
Shimoda, Shinji
Hayashi, Jun
JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 495 - 501
[50] Prediction of sustained off-treatment response in chronic hepatitis B patients undergoing pegylated interferon treatment by a new scoring model
Wang, Yin-Chen
Huang, Yi-Hsiang
Yang, Sien-Sing
Su, Chien-Wei
Lee, Kuei-Chuan
Lin, Han-Chieh
HEPATOLOGY, 2015, 62 : 1208A - 1208A

← 1 2 3 4 5 →